PTEN and prostate carcinoma: Genetic mouse models confirmed that Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance, since their loss induces NE phenotype through induction of SOX2 expression in prostate cancer initiated by the inactivation of PTEN [38,39].